Translational Research - Biomarkers - Rare Diseases
Precision Medicine in Pediatrics: Biomarkers and Assay Development
|
Precision provides comprehensive immune monitoring services, from the development of customized assays for early clinical studies to managing the logistical and immune monitoring testing needs of global, registrational trials. We leverage multiple technology platforms on a global scale, including proprietary innovations like Epiontis ID®.
Customized assays to detect cytokines or proteins of interest utilizing ELISA, Luminex, MSD, SIMOA, and Western Blotting
ELISpot and FluoroSpot - including custom assays in support of gene therapy immunogenicity - from preclinical through clinical development
Understand target expression, adaptive and innate immune responses at the gene expression level. Technologies we use for gene expression profiling include NanoString, Illumina RNA-seq, ddPCR, and qPCR.
Precision’s immune monitoring services are strengthened by a global logistics network, designed to safeguard sample integrity and maximize data reliability.
Our extensive global biorepository footprint includes the first to receive CAP certification. Currently, we are responsible for the storage of >20 million biospecimens under controlled conditions. We can accommodate any type of fluid or solid biological specimen at controlled ambient temperatures, +4℃, -20℃, -80℃, or in liquid nitrogen vapor.
The biorepository includes numerous security and safety features:
Precision for Medicine offers a suite of flow cytometry services tailored to the intricate demands of modern scientific research and therapeutic development.
Within our suite of immune monitoring services, Epiontis ID® proprietary technology stands out by offering an epigenetic approach to cell profiling. See how it works.
Read our blog to gain more insights and discover work that Precision has supported.
Translational Research - Biomarkers - Rare Diseases
Translational Research - Biomarkers - Assays
Translational Research - Biomarkers - Assays